File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Scopus: eid_2-s2.0-0022645675
- PMID: 3001282
- WOS: WOS:A1986AXX2600027
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Oxytocin causes endothelium-depending relaxations of canine basilar arteries by activating V1-vasopressinergic receptors
Title | Oxytocin causes endothelium-depending relaxations of canine basilar arteries by activating V1-vasopressinergic receptors |
---|---|
Authors | |
Issue Date | 1986 |
Publisher | American Society for Pharmacology and Experimental Therapeutics. The Journal's web site is located at http://jpet.aspetjournals.org |
Citation | Journal Of Pharmacology And Experimental Therapeutics, 1986, v. 236 n. 1, p. 166-170 How to Cite? |
Abstract | Experiments were designed to study the effects of oxytocin on canine basilar and femoral arteries and to compare these with the effects of vasopressin. Rings of the arteries were suspended in physiological salt solution for isometric tension recording. Oxytocin and vasopressin caused endothelium-dependent relaxation of basilar arteries contracted with prostaglandin F(2α). Vasopressin was more potent than oxytocin. In the femoral artery, in the two hormones caused endothelium-independent contractions with the same order of potency. The relaxation of the basilar artery occurred at lower concentrations of each substance than the contractions of the femoral artery. The relaxations in response to both agonists were inhibited competitively, and the contractions noncompetitively, by the V1-vasopressinergic antagonist d(CH2)5 Tyr(Me)AVP; the antagonist did not affect endothelium-dependent relaxations in response to bradykinin. Thus, both oxytocin and vasopressin cause endothelium-dependent relaxation of the basilar artery by activating V1-vasopressinergic receptors; the contractions of femoral arteries that they cause also may be mediated in part by V1-vasopresinergic receptors. |
Persistent Identifier | http://hdl.handle.net/10722/170823 |
ISSN | 2023 Impact Factor: 3.1 2023 SCImago Journal Rankings: 0.829 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Katusic, ZS | en_US |
dc.contributor.author | Shepherd, JT | en_US |
dc.contributor.author | Vanhoutte, PM | en_US |
dc.date.accessioned | 2012-10-30T06:11:01Z | - |
dc.date.available | 2012-10-30T06:11:01Z | - |
dc.date.issued | 1986 | en_US |
dc.identifier.citation | Journal Of Pharmacology And Experimental Therapeutics, 1986, v. 236 n. 1, p. 166-170 | en_US |
dc.identifier.issn | 0022-3565 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/170823 | - |
dc.description.abstract | Experiments were designed to study the effects of oxytocin on canine basilar and femoral arteries and to compare these with the effects of vasopressin. Rings of the arteries were suspended in physiological salt solution for isometric tension recording. Oxytocin and vasopressin caused endothelium-dependent relaxation of basilar arteries contracted with prostaglandin F(2α). Vasopressin was more potent than oxytocin. In the femoral artery, in the two hormones caused endothelium-independent contractions with the same order of potency. The relaxation of the basilar artery occurred at lower concentrations of each substance than the contractions of the femoral artery. The relaxations in response to both agonists were inhibited competitively, and the contractions noncompetitively, by the V1-vasopressinergic antagonist d(CH2)5 Tyr(Me)AVP; the antagonist did not affect endothelium-dependent relaxations in response to bradykinin. Thus, both oxytocin and vasopressin cause endothelium-dependent relaxation of the basilar artery by activating V1-vasopressinergic receptors; the contractions of femoral arteries that they cause also may be mediated in part by V1-vasopresinergic receptors. | en_US |
dc.language | eng | en_US |
dc.publisher | American Society for Pharmacology and Experimental Therapeutics. The Journal's web site is located at http://jpet.aspetjournals.org | en_US |
dc.relation.ispartof | Journal of Pharmacology and Experimental Therapeutics | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Arginine Vasopressin - Analogs & Derivatives - Pharmacology | en_US |
dc.subject.mesh | Basilar Artery - Drug Effects | en_US |
dc.subject.mesh | Bradykinin - Pharmacology | en_US |
dc.subject.mesh | Deamino Arginine Vasopressin - Pharmacology | en_US |
dc.subject.mesh | Dogs | en_US |
dc.subject.mesh | Endothelium - Drug Effects | en_US |
dc.subject.mesh | Femoral Artery - Drug Effects | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Oxytocin - Pharmacology | en_US |
dc.subject.mesh | Receptors, Angiotensin - Drug Effects | en_US |
dc.subject.mesh | Receptors, Cell Surface - Drug Effects | en_US |
dc.subject.mesh | Receptors, Vasopressin | en_US |
dc.subject.mesh | Vasodilation - Drug Effects | en_US |
dc.subject.mesh | Vasopressins - Pharmacology | en_US |
dc.title | Oxytocin causes endothelium-depending relaxations of canine basilar arteries by activating V1-vasopressinergic receptors | en_US |
dc.type | Article | en_US |
dc.identifier.email | Vanhoutte, PM:vanhoutt@hku.hk | en_US |
dc.identifier.authority | Vanhoutte, PM=rp00238 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.pmid | 3001282 | - |
dc.identifier.scopus | eid_2-s2.0-0022645675 | en_US |
dc.identifier.volume | 236 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.spage | 166 | en_US |
dc.identifier.epage | 170 | en_US |
dc.identifier.isi | WOS:A1986AXX2600027 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Katusic, ZS=7006971465 | en_US |
dc.identifier.scopusauthorid | Shepherd, JT=7401742522 | en_US |
dc.identifier.scopusauthorid | Vanhoutte, PM=7202304247 | en_US |
dc.identifier.issnl | 0022-3565 | - |